Chronic diseases such as heart disease, stroke, and cancer are increasingly affecting the population. Currently, the treatment of chronic diseases and public health services still heavily rely on imported medical devices.
Meanwhile, the availability of domestically produced medical equipment remains very limited and needs to be rapidly improved. The enactment of Law No. 17 of 2023 opens up opportunities for domestic industries to accelerate the independent production of medical devices.
This law clearly mandates special attention to the provision of affordable healthcare services, especially through the development of self-sufficiency in the production of medical devices.